Olivier R. Martin

<i>In vitro</i> inhibition and intracellular enhancement of lysosomal α‐galactosidase A activity in Fabry lymphoblasts by 1‐deoxygalactonojirimycin and its derivatives

Naoki Asano, Haruhisa Kizu, Kyoko Ikeda et al. · European Journal of Biochemistry · 2000 · 240 citations · Full text

Intracellular Enhancement, Enzymatic Modification, Cellular Physiology +16

Design and Synthesis of Highly Potent and Selective Pharmacological Chaperones for the Treatment of Gaucher's disease

Philippe Compain, Olivier R. Martin, Charlotte Boucheron et al. · ChemBioChem · 2006 · 161 citations

Residual Activity, Glycosylation, Biochemistry +14

α-1-C-Octyl-1-deoxynojirimycin as a pharmacological chaperone for Gaucher disease

Liang Yu, Kyoko Ikeda, Atsushi Kato et al. · Bioorganic & Medicinal Chemistry · 2006 · 101 citations · Full text

Gaucher Disease, Medicine, Pharmacotherapy +4

Synthesis and conformational studies of .beta.-(1.fwdarw.6)- and .beta.,.beta.-(1.fwdarw.1)-linked C-disaccharides

Olivier R. Martin, Wen Lai · The Journal of Organic Chemistry · 1993 · 73 citations

Pharmaceutical Science, Glycosylation, Biochemistry +11

First total synthesis of (+)-hyacinthacine A2

Lauriane Rambaud, Philippe Compain, Olivier R. Martin · Tetrahedron Asymmetry · 2001 · 72 citations

Biosynthesis, Bioorganic Chemistry, Biochemistry +4